Neuronetics
STIM
86 hedge funds and large institutions have $48.4M invested in Neuronetics in 2026 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 28 closing their positions.
44% more call options, than puts
Call options by funds: $118K | Put options by funds: $82K
16% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 25
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6.64% less ownership
Funds ownership: 60.12% → 53.48% (-6.6%)
13% less funds holding
Funds holding: 99 → 86 (-13)
20% less capital invested
Capital invested by funds: $60.4M → $48.4M (-$12M)
43% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$1.89M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$707K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$502K |
| 4 |
FCM
FourWorld Capital Management
New York
|
+$371K |
| 5 |
Millennium Management
New York
|
+$290K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.98M |
| 2 |
BlackRock
New York
|
-$2.51M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$861K |
| 4 |
State Street
Boston,
Massachusetts
|
-$804K |
| 5 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
-$787K |
STIM Hedge Fund Activity: Q2 2026 in Review
86 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q2 2026, worth a combined $48.4M — down 20% from $60.4M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of STIM and 16 opened new positions — a net loss of 12 holders — while 25 trimmed existing stakes and 29 added.
The largest buyer was Wexford Capital, adding an estimated $1.89M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $3.98M sold.
- 86 institutional investors held Neuronetics (STIM) as of Q2 2026, down from 99 in Q1 2026.
- Funds reported $48.4M of Neuronetics stock for Q2 2026, down 20% quarter-over-quarter.
- 16 funds opened new Neuronetics positions in Q2 2026 and 28 closed out, a net change of -12 holders.
- The largest Neuronetics buyer in Q2 2026 was Wexford Capital, an estimated $1.89M added.
- The largest Neuronetics seller in Q2 2026 was Balyasny Asset Management, an estimated $3.98M sold.
Based on aggregated 13F filings for Q2 2026.